Related Experiment Videos
Blood pressure decrease and responsiveness to renin-releasing stimuli under increasing doses of propranolol in
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys.
Journal of human hypertension·2015
Transforming nanostructured chitin from crustacean waste into beneficial health products: a must for our society.
Nanotechnology, science and applications·2013
Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies.
Journal of human hypertension·2011
The Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS) study: rationale and study design.
Journal of human hypertension·2011
The role of prostaglandins in the pathogenesis of hypertension.
Clinical science and molecular medicine. Supplement·1978
Implications of prostacyclin generation for modulation of vascular tone.
Clinical science and molecular medicine. Supplement·1978
The effects of calcium and calcium-ionophores (X 537 A and A 23187) on renin release in the isolated perfused rat kidney.
Clinical science and molecular medicine. Supplement·1978
Hypoxanthine--guanine phosphoribosyltransferase activity in blood and skeletal muscles of normal and dystrophic mice.
Clinical science and molecular medicine. Supplement·1978
The formation of tri-iodothyronine and reverse tri-iodothyronine from thyroxine in isolated rat renal tubules.
Clinical science and molecular medicine. Supplement·1978
A survey of salivary kallikrein and amylase in a population of schoolgirls, throughout the menstrual cycle.
Clinical science and molecular medicine. Supplement·1978
Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.
Canadian journal of kidney health and disease·2026
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.
Therapeutic advances in neurological disorders·2026